BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/27/2026 7:13:53 AM | Browse: 2 | Download: 0
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Effect of the Internet+ 5A nursing model on patients with middle- and late-stage digestive tract tumors pain
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lei Wang, Xiao-Qin Ma, Chen-Xia Ju and Jue Fu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Youth Science and Technology Project of Changzhou Municipal Health Commission |
QN202456 |
|
| Corresponding Author |
Chen-Xia Ju, Nursing department, Changzhou Tumor Hospital, No. 68, Honghe Road, Changzhou 213000, Jiangsu Province, China. 15995002998@163.com |
| Key Words |
Internet+; 5A nursing model; Middle- and late-stage digestive tract tumors; Pain; Numerical Rating Scale; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; Chinese Version of the Self-Management Efficacy Scale for Cancer Patients; Chinese Version of the American Pain Society Patient Outcome Questionnaire |
| Core Tip |
This study investigates the effect of the Internet+ 5A nursing model on patients with middle- and late-stage digestive tract tumors pain. A prospective study of 100 patients demonstrated that the intervention group, compared to the control group receiving routine care, yielded superior outcomes. Specifically, it significantly reduced pain intensity (Numerical Rating Scale), and enhanced overall quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30). The model also boosted self-management efficacy and improved various patient-reported outcomes. The Internet+ 5A nursing model is concluded to be effective and merits clinical application. |
| Citation |
Wang L, Ma XQ, Ju CX, Fu J. Effect of the Internet+ 5A nursing model on patients with middle- and late-stage digestive tract tumors pain. World J Gastrointest Oncol 2026; In press |
 |
Received |
|
2025-11-25 09:08 |
 |
Peer-Review Started |
|
2025-11-25 09:08 |
 |
First Decision by Editorial Office Director |
|
2025-12-18 09:08 |
 |
Return for Revision |
|
2025-12-18 09:08 |
 |
Revised |
|
2026-01-04 07:13 |
 |
Publication Fee Transferred |
|
2026-01-07 02:23 |
 |
Second Decision by Editor |
|
2026-01-27 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-27 07:13 |
 |
Articles in Press |
|
2026-01-27 07:13 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345